ClinicalTrials.Veeva

Menu

Use of Consent Language and Mode to Improve Interactive Voice Response Survey in Colombia and Uganda

Johns Hopkins Bloomberg School of Public Health logo

Johns Hopkins Bloomberg School of Public Health

Status

Completed

Conditions

Noncommunicable Diseases
Surveys and Questionnaires

Treatments

Other: Active Opt-in
Other: Modified Introduction
Other: Active Opt-out
Other: Passive Opt-in

Study type

Interventional

Funder types

Other

Identifiers

NCT04394520
00007318-6.1

Details and patient eligibility

About

This study evaluates the effect of one new form of introduction language and three new modes of providing consent on interactive voice response (IVR) survey cooperation, response, refusal and contact rates, as compared to control group, in Colombia and Uganda.

Full description

Using random digit dialing (RDD) sampling technique, RDD participants will be randomized to one of five introduction and consent combinations and then have them complete noncommunicable disease risk factor survey with an additional module regarding their understanding of the survey and of its voluntariness. This mobile phone survey will be sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; If you are female, press 2). This study will be conducted in both Colombia and Uganda.

Enrollment

3,786 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Access to a mobile phone
  • Greater or equal to 18 years of age
  • In Colombia, conversant in the Spanish language. In Uganda, conversant in Luo, Luganda, Runyakitara or English languages.

Exclusion criteria

  • Less than 18 years of age

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

3,786 participants in 5 patient groups

Control
No Intervention group
Description:
No change will be made to the introduction content or the consent mode (active opt-in and active opt-out) from other related trials
Modified Intro, Standard Consent
Experimental group
Description:
Modified introductory language will be used, but the consent structure (active opt-in and active opt-out) will remain the same.
Treatment:
Other: Modified Introduction
Modified Intro, Active Opt-in
Experimental group
Description:
Modified introductory language will be used, and the consent mode will be changed to active opt-in only.
Treatment:
Other: Modified Introduction
Other: Active Opt-in
Modified Intro, Active Opt-out
Experimental group
Description:
Modified introductory language will be used, and the consent mode will be changed to active opt-out only.
Treatment:
Other: Modified Introduction
Other: Active Opt-out
Modified Intro, Passive Opt-in
Experimental group
Description:
Modified introductory language will be used, and the consent mode will be changed to passive opt-in only.
Treatment:
Other: Modified Introduction
Other: Passive Opt-in

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems